13/07/2022
After the outbreak of COVID-19, health has become the key word for everyone. According to the reports released by authoritative institutions such as Innova and ADM, one of the latest consumption trends in the food industry is the continuous blessing of functionality focusing on immunity and intestinal health in 2022.
As early as 1934, the scientists found that breastfed newborns had a 50% lower incidence of gastrointestinal infections compared to artificial feeding; modern epidemiological studies have found that breastfeeding provides a variety of bioactive components, including breast milk polysaccharides - Hyaluronic acid, and hyaluronic acid provided by human milk plays an important role in the formation of the "innate" gastrointestinal defenses of the newborn.
As a result, Bloomage Biotech has carried out in-depth research on Hyaluronic acid in intestinal health. The research results accessed by Harvard university shows that oral Hyaluronic acid plays an important role in improving intestinal inflammation and promoting the growth of intestinal probiotics (especially Akk), and regulating intestinal barrier function. Based on Bloomage's multiple efficacy tests, Bloomage finally screened out the optimal molecular weight compound, UltraHA®-GI-001, which brings multiple health benefits of immunity enhencement, flora regulation, and mucosal protection to the intestinal tract. Bloomage UltraHA®-GI-001 promotes younger intestinal tract.
